The T cell immune response against SARS-CoV-2

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• Adaptive immune response, particularly T cells, is key to SARS-CoV-2 outcomes and vaccine efficacy.
• T cell responses are early indicators of protection but can be impaired in severe COVID-19.
• Cross-reactivity from seasonal coronaviruses and broad T cell memory contribute to protection.

Purpose of the Study:

• To highlight the central role of T cell immunity in SARS-CoV-2 infection control.
• To emphasize the underappreciated importance of T cell responses in COVID-19.
• To discuss the implications of T cell responses for vaccine efficacy and variant protection.

Main Methods:

• Analysis of adaptive immune responses in SARS-CoV-2 infection.
• Evaluation of T cell cross-reactivity and memory.
• Assessment of T cell responses to current and novel COVID-19 vaccines.

Main Results:

• T cell responses correlate with protection but are impaired in severe disease.
• Broad T cell recognition of SARS-CoV-2 epitopes, including variants like Omicron, is observed.
• COVID-19 vaccines induce robust T cell responses contributing to protection against severe outcomes.

Conclusions:

• T cell immunity is a critical determinant of clinical outcomes in SARS-CoV-2 infection.
• Broad T cell memory and cross-reactivity provide sustained protection against viral evolution.
• Enhancing T cell responses through vaccination strategies is vital for combating COVID-19.